Literature DB >> 11041455

Accuracy considerations when using early (four- or six-hour) radioactive iodine uptake to predict twenty-four-hour values for radioactive iodine dosage in the treatment of Graves' disease.

L F Morris1, A D Waxman, G D Braunstein.   

Abstract

Although literature has offered methods to predict 24-hour radioactive iodine uptake values from early (4- to 6-hour) measurements, the resultant dosage errors have not been examined. Potential errors include underdosage, overdosage, and a failure to recognize rapid turnover patients (early-to-late uptake ratios > or = 1) who are at high risk for treatment failure and full-body radiation exposure. We developed and tested a novel method for minimizing error involved in using a single early uptake measurement to derive late uptake. From a retrospective analysis of 203 Graves' disease patients, receiver operating characteristic (ROC) curve analysis enabled us to identify patients likely to experience rapid turnover and therefore should receive 24-hour studies. Twenty-four-hour uptake measurements are necessary with 77% or more 4-hour uptake values and 80% or more 6-hour values. After eliminating these patients, we developed linear regression equations to predict the 24-hour uptake from 4-hour (n = 61) and 6-hour (n = 22) rule groups, testing their efficacy on separate 4-hour (n = 61) and 6-hour (n = 21) patient groups. We also used our test population to measure error in four early-to-late uptake conversion formulas presented in the literature. Error involved in these predictions ranged from a 10.6% overestimate for 4-hour calculations to a 5.9% underestimate for 6-hour calculations. When applied to two dosage formulas incorporating gland size, absorbed dose, and 24-hour uptake, average dosage error was 7%. In comparison to the other sources of error radioactive iodine (131I) dosimetry, potential error in predicting 24-hour uptake from 4- or 6-hour uptake values is low.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11041455     DOI: 10.1089/thy.2000.10.779

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  5 in total

1.  Differentiation between Graves' disease and painless thyroiditis by diffusion-weighted imaging, thyroid iodine uptake, thyroid scintigraphy and serum parameters.

Authors:  Zhaowei Meng; Guizhi Zhang; Haoran Sun; Jian Tan; Chunshun Yu; Weijun Tian; Weidong Li; Zhiqiang Yang; Mei Zhu; Qing He; Yujie Zhang; Shugao Han
Journal:  Exp Ther Med       Date:  2015-04-17       Impact factor: 2.447

2.  Is There Any Need for Adjusting 131I Activity for the Treatment of High Turnover Graves' Disease Compared to Normal Turnover Patients? Results from a Retrospective Cohort Study Validated by Propensity Score Analysis.

Authors:  Saurabh Arora; Chandrasekhar Bal
Journal:  Nucl Med Mol Imaging       Date:  2021-01-07

3.  Analysis of risk factors of rapid thyroidal radioiodine-131 turnover in Graves' disease patients.

Authors:  Ruiguo Zhang; Jian Tan; Renfei Wang; Guizhi Zhang; Qiang Jia; Zhaowei Meng; Yueqian Zhang
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

4.  Calculation of therapeutic activity of radioiodine in Graves' disease by means of Marinelli's formula, using technetium (99mTc) scintigraphy.

Authors:  Piotr Szumowski; Małgorzata Mojsak; Saeid Abdelrazek; Monika Sykała; Anna Amelian-Fiłonowicz; Dorota Jurgilewicz; Janusz Myśliwiec
Journal:  Endocrine       Date:  2016-08-24       Impact factor: 3.633

5.  Prediction of thyroidal 131I effective half-life in patients with Graves' disease.

Authors:  Ruiguo Zhang; Guizhi Zhang; Renfei Wang; Jian Tan; Yajing He; Zhaowei Meng
Journal:  Oncotarget       Date:  2017-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.